期刊
BMJ GLOBAL HEALTH
卷 6, 期 12, 页码 -出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/bmjgh-2021-007468
关键词
pneumonia; systematic review; child health; health economics
资金
- Bill & Melinda Gates Foundation [INV--001132]
- Elma Foundation
- Bill and Melinda Gates Foundation [INV-001132] Funding Source: Bill and Melinda Gates Foundation
This study found that strengthening oxygen systems may reduce hospital-based pneumonia mortality in low-income countries, and it could be cost-effective. However, due to the non-randomized design of the studies, moderate risk of bias, and low overall certainty of the evidence, further implementation trials with more rigorous designs are needed to strengthen the certainty in the effect estimate.
Objectives Increasing access to oxygen services may improve outcomes among children with pneumonia living in low-resource settings. We conducted a systematic review to estimate the impact and cost-effectiveness of strengthening oxygen services in low-income and middle-income countries with the objective of including oxygen as an intervention in the Lives Saved Tool. Design We searched EMBASE and PubMed on 31 March 2021 using keywords and MeSH terms related to 'oxygen', 'pneumonia' and 'child' without restrictions on language or date. The risk of bias was assessed for all included studies using the quality assessment tool for quantitative studies, and we assessed the overall certainty of the evidence using Grading of Recommendations, Assessment, Development and Evaluations. Meta-analysis methods using random effects with inverse-variance weights was used to calculate a pooled OR and 95% CIs. Programme cost data were extracted from full study reports and correspondence with study authors, and we estimated cost-effectiveness in US dollar per disability-adjusted life-year (DALY) averted. Results Our search identified 665 studies. Four studies were included in the review involving 75 hospitals and 34 485 study participants. We calculated a pooled OR of 0.52 (95% CI 0.39 to 0.70) in favour of oxygen systems reducing childhood pneumonia mortality. The median cost-effectiveness of oxygen systems strengthening was $US62 per DALY averted (range: US$44-US$225). We graded the risk of bias as moderate and the overall certainty of the evidence as low due to the non-randomised design of the studies. Conclusion Our findings suggest that strengthening oxygen systems is likely to reduce hospital-based pneumonia mortality and may be cost-effective in low-resource settings. Additional implementation trials using more rigorous designs are needed to strengthen the certainty in the effect estimate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据